SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-011611
Filing Date
2023-04-03
Accepted
2023-04-03 16:32:01
Documents
18

Document Format Files

Seq Description Document Type Size
1 DEF 14A crbp-20230403.htm   iXBRL DEF 14A 1112568
2 GRAPHIC img114954070_0.jpg GRAPHIC 26074
3 GRAPHIC img114954070_1.jpg GRAPHIC 22436
4 GRAPHIC img114954070_2.jpg GRAPHIC 49966
5 GRAPHIC img114954070_3.jpg GRAPHIC 57345
  Complete submission text file 0000950170-23-011611.txt   2331463

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbp-20230403_def.xml EX-101.DEF 4600
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbp-20230403.xsd EX-101.SCH 4626
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbp-20230403_pre.xml EX-101.PRE 6100
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbp-20230403_lab.xml EX-101.LAB 8969
12 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20230403_htm.xml XML 311369
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37348 | Film No.: 23793193
SIC: 2834 Pharmaceutical Preparations